Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD34+ Stem Cells for Immunosuppression Minimization in Intestinal Transplantation
NCT04804891Phase 1Recruiting
- Sponsor
- Columbia University
- Start
- Oct 2021
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Phase 1, open-label trial in Intestinal Transplantation (IT) (2 arms), sponsored by Columbia University. Primary endpoint: Total number of participants with moderate to severe Graft-Versus-Host Disease at 4 years. Started Oct 2021; status: recruiting.
02
Conditions
Intestinal Transplantation (IT)
Beyond the preview
Go deeper on NCT04804891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04804891.